Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
ZuraPrep is being evaluated for efficacy as a preoperative skin preparation solution to
demonstrate its immediate and persistent antimicrobial properties. At least 72 subjects will
be randomized utilizing bilateral applications on abdomen and groin. ZuraPrep active product
and reference positive control will be compared; ZuraPrep non-active and negative control
will be compared. Each subject will receive two of the planned treatments, one on the left
side of body and one of the right. Study duration for subjects - 3 to 4 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Zurex Pharma, Inc.
Treatments:
Chlorhexidine Chlorhexidine gluconate Methylene Blue